ACM
XERS icon

Aquatic Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Aquatic Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
+199,983
New +$1.28M 0.05% 434
2025
Q4 		– Sell
-83,000
Closed -$676K – 1826
2025
Q3 		$676K Buy
+83,000
New +$551K 0.01% 795
2025
Q1 		– Sell
-14,684
Closed -$49.8K – 1674
2024
Q4 		$49.8K Buy
+14,684
New +$47.2K ﹤0.01% 1163

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aquatic Capital Management's XERS Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 199,983 shares worth $1.58M. The stake represents 0.05% of the portfolio and ranks #434 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in XERS as recently as Q3 2025.

Aquatic Capital Management first reported a position in XERS in Q4 2024 and has held it in 3 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Aquatic Capital Management held 199,983 shares of Xeris Biopharma Holdings worth $1.58M as of Q2 2026.
  • Xeris Biopharma Holdings was a new Aquatic Capital Management position in Q2 2026.
  • Xeris Biopharma Holdings made up 0.05% of Aquatic Capital Management's portfolio in Q2 2026, its #434 holding.
  • Aquatic Capital Management first reported a position in Xeris Biopharma Holdings in Q4 2024 and has held it in 3 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.